- Home
- QCLS vs CCEL Comparison
QCLS vs CCEL Comparison
Compare QCLS & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QCLS | CCEL |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 29.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | QCLS | CCEL |
|---|---|---|
| Price | $4.03 | $4.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 396.5K | 5.4K |
| Earning Date | 04-15-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 4.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $405.00 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $2.50 | $2.72 |
| 52 Week High | $8.17 | $5.43 |
Technical Indicators
Market Signals| Indicator | QCLS | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 51.86 | 64.09 |
| Support Level | $3.86 | $3.02 |
| Resistance Level | $4.66 | $4.41 |
| Average True Range (ATR) | 0.28 | 0.20 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 53.68 | 100.00 |
Price Performance
Historical ComparisonAbout QCLS Q/C Technologies Inc.
Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.